Filter News
Area of Research
News Topics
- (-) Artificial Intelligence (1)
- (-) Biomedical (1)
- (-) Computer Science (3)
- (-) Machine Learning (1)
- (-) Nuclear Energy (2)
- (-) Transportation (2)
- 3-D Printing/Advanced Manufacturing (5)
- Advanced Reactors (1)
- Bioenergy (5)
- Clean Water (1)
- Composites (1)
- Cybersecurity (1)
- Environment (4)
- Isotopes (1)
- Materials Science (2)
- Neutron Science (2)
- Security (2)
- Summit (1)
- Sustainable Energy (5)
Media Contacts
A technology developed at the ORNL and scaled up by Vertimass LLC to convert ethanol into fuels suitable for aviation, shipping and other heavy-duty applications can be price-competitive with conventional fuels
Researchers at the Department of Energy’s Oak Ridge National Laboratory have received five 2019 R&D 100 Awards, increasing the lab’s total to 221 since the award’s inception in 1963.
ORNL and The University of Toledo have entered into a memorandum of understanding for collaborative research.
IDEMIA Identity & Security USA has licensed an advanced optical array developed at Oak Ridge National Laboratory. The portable technology can be used to help identify individuals in challenging outdoor conditions.
The Department of Energy’s Oak Ridge National Laboratory is collaborating with industry on six new projects focused on advancing commercial nuclear energy technologies that offer potential improvements to current nuclear reactors and move new reactor designs closer to deployment.
The United Kingdom’s National Nuclear Laboratory and the U.S. Department of Energy’s Oak Ridge National Laboratory have agreed to cooperate on a wide range of nuclear energy research and development efforts that leverage both organizations’ unique expertise and capabilities.
The U.S. Department of Energy’s Oak Ridge National Laboratory today unveiled Summit as the world’s most powerful and smartest scientific supercomputer.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.